Form 4 holding
Director
CODEXIS, INC.
- Security class
- Common Stock
- Shares / value
- 727,053
- Estimated value
- $1,343,085
- Report date
- 11 Nov 2025
- Price
- $1.85
- Ownership
- Direct
Stephen G. Dilly
Insider Reports History
- Reporting-owner location
- San Mateo, CA
- Latest reporting-owner signature
-
/s/ Georgia Erbez, as Attorney-in-Fact for Stephen G. Dilly
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Stephen G. Dilly
Form 4 holding
Director
CODEXIS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 66,350
- Estimated value
- Report date
- 17 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
CEO and President, Director
Sierra Oncology, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 01 Jul 2022
- Price
- $55.00
- Ownership
- Direct
Form 4 holding
CEO and President, Director
Sierra Oncology, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 01 Jul 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Stephen G. Dilly
4
CDXS
CODEXIS, INC.
- Report period
- 17 Jun 2026
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 18 Jun 2026, 16:06
- Role
- Director
- Next action
- Open filing details
4
CDXS
CODEXIS, INC.
- Report period
- 11 Nov 2025
- Transactions
- 1
- Transaction value
- +$92,365
- Accepted by SEC
- 12 Nov 2025, 16:31
- Role
- Director
- Next action
- Open filing details
4
CDXS
CODEXIS, INC.
- Report period
- 05 Feb 2025
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 07 Feb 2025, 20:15
- Role
- President and Chief Executive Officer, Director
- Next action
- Open filing details
4
CDXS
CODEXIS, INC.
- Report period
- 01 Jan 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 02 Jan 2024, 21:23
- Role
- President and Chief Executive Officer, Director
- Next action
- Open filing details
4
CDXS
CODEXIS, INC.
- Report period
- 08 Sep 2023
- Transactions
- 1
- Transaction value
- +$100,952
- Accepted by SEC
- 12 Sep 2023, 16:06
- Role
- President and Chief Executive Officer, Director
- Next action
- Open filing details
4
CDXS
CODEXIS, INC.
- Report period
- 21 Feb 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 21 Feb 2023, 19:26
- Role
- President and Chief Executive Officer, Director
- Next action
- Open filing details
4
CDXS
CODEXIS, INC.
- Report period
- 08 Feb 2023
- Transactions
- 3
- Transaction value
- -$252,212
- Accepted by SEC
- 09 Mar 2023, 20:15
- Role
- President and Chief Executive Officer, Director
- Next action
- Open filing details
4
CDXS
CODEXIS, INC.
- Report period
- 01 Aug 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 03 Aug 2022, 18:25
- Role
- President and Chief Executive Officer, effective as of August 9, 2022, Director
- Next action
- Open filing details
4
Sierra Oncology, Inc.
- Report period
- 01 Jul 2022
- Transactions
- 5
- Transaction value
- -$275,000
- Accepted by SEC
- 01 Jul 2022, 16:35
- Role
- CEO and President, Director
- Next action
- Open filing details
4
Sierra Oncology, Inc.
- Report period
- 17 Jun 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 17 Jun 2022, 16:10
- Role
- CEO and President, Director
- Next action
- Open filing details
4
CDXS
CODEXIS, INC.
- Report period
- 14 Jun 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 16 Jun 2022, 16:14
- Role
- Director
- Next action
- Open filing details
4
Sierra Oncology, Inc.
- Report period
- 14 Mar 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 14 Mar 2022, 16:50
- Role
- CEO and President, Director
- Next action
- Open filing details
4
Sierra Oncology, Inc.
- Report period
- 28 Jan 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 28 Jan 2022, 17:32
- Role
- CEO and President, Director
- Next action
- Open filing details
4
CDXS
CODEXIS, INC.
- Report period
- 15 Jun 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 17 Jun 2021, 16:20
- Role
- Director
- Next action
- Open filing details
4
Sierra Oncology, Inc.
- Report period
- 19 May 2021
- Transactions
- 1
- Transaction value
- +$89,150
- Accepted by SEC
- 20 May 2021, 18:59
- Role
- CEO and President, Director
- Next action
- Open filing details